{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:58:41Z","timestamp":1790787521355,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T00:00:00Z","timestamp":1283817600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000818","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T20:21:29Z","timestamp":1283890889000},"page":"e818","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":94,"title":["Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent"],"prefix":"10.1371","volume":"4","author":[{"given":"Filip","family":"Meheus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manica","family":"Balasegaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Olliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Rijal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Abul","family":"Faiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marleen","family":"Boelaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,9,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic.","volume":"31","author":"S Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0035-9203(03)90167-2","article-title":"Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline.","volume":"97","author":"S Rijal","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-3156.2007.01974.x","article-title":"Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal\u2013the challenges for diagnosis and treatment.","volume":"13","author":"S Sundar","year":"2008","journal-title":"Trop Med Int Health"},{"key":"ref4","article-title":"Regional Strategic Framework for Elimination of Kala-azar from the South-East Asia Region (2005\u20132015)","year":"2005"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for Visceral leishmaniasis in India.","volume":"356","author":"S Sundar","year":"2007","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).","volume":"22","author":"K Seifert","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance.","volume":"6","author":"A Bryceson","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/507530","article-title":"Liposomal amphotericin B for the treatment of visceral leishmaniasis.","volume":"43","author":"C Bern","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis.","volume":"10","author":"J van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/380971","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.","volume":"38","author":"S Sundar","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.","volume":"196","author":"SK Bhattacharya","year":"2007","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis.","volume":"347","author":"S Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4269\/ajtmh.2002.66.143","article-title":"Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.","volume":"66","author":"S Sundar","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/377542","article-title":"Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study.","volume":"37","author":"S Sundar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India.","volume":"362","author":"S Sundar","year":"2010","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/591972","article-title":"New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.","volume":"47","author":"S Sundar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/bmj.323.7310.419","article-title":"Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.","volume":"323","author":"S Sundar","year":"2001","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-3156.2008.02195.x","article-title":"Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India.","volume":"14","author":"P Olliaro","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/j.1365-3156.2006.01732.x","article-title":"Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India.","volume":"11","author":"F Meheus","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref20","article-title":"Unit Costs of Health Care Inputs in Low and Middle Income Regions.","author":"JA Mulligan","year":"2003"},{"key":"ref21","article-title":"Making choices in health: WHO guide to cost-effectiveness analysis","author":"T Tan Torres","year":"2003"},{"key":"ref22","first-page":"394","article-title":"Availability of miltefosine for the treatment of kala-azar in India.","volume":"83","author":"S Sundar","year":"2005","journal-title":"Bull World Health Organ"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-3156.2008.02195.x","article-title":"Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India.","volume":"14","author":"P Olliaro","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1365-3156.2006.01647.x","article-title":"Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India.","volume":"11","author":"SP Singh","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0035-9203(00)90255-4","article-title":"Socio-economics of visceral leishmaniasis in Bihar (India).","volume":"94","author":"CP Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref26","first-page":"62","article-title":"Epidemiology of visceral leishmaniasis in India.","volume":"12","author":"D Bora","year":"1999","journal-title":"Natl Med J India"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0035-9203(00)90255-4","article-title":"Socio-economics of visceral leishmaniasis in Bihar (India).","volume":"94","author":"CP Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1086\/605438","article-title":"Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment.","volume":"49","author":"S Sundar","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-3156.2006.01782.x","article-title":"Drug policy for visceral leishmaniasis: a cost-effectiveness analysis.","volume":"12","author":"V Vanlerberghe","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-3156.2009.02306.x","article-title":"Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India.","volume":"14","author":"P Olliaro","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-3156.2009.02279.x","article-title":"The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India.","volume":"14","author":"M Boelaert","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.trstmh.2005.09.017","article-title":"The economic burden of visceral leishmaniasis for households in Nepal.","volume":"100","author":"S Rijal","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-3156.2006.01604.x","article-title":"The economic impact of visceral leishmaniasis on households in Bangladesh.","volume":"11","author":"SD Anoopa","year":"2006","journal-title":"Trop Med Int Health"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0035-9203(00)90130-5","article-title":"A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis.","volume":"94","author":"CP Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0035-9203(92)90150-B","article-title":"Treatment of visceral leishmaniasis (kala-azar) with aminosidine ( = paromomycin)-antimonial combinations, a pilot study in Bihar, India.","volume":"86","author":"CP Thakur","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/380638","article-title":"Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.","volume":"38","author":"SK Bhattacharya","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/01.inf.0000066877.72624.cb","article-title":"Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.","volume":"22","author":"S Sundar","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/318122","article-title":"Short-course of oral miltefosine for treatment of visceral leishmaniasis.","volume":"31","author":"S Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.316.7139.1200","article-title":"Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India.","volume":"316","author":"TK Jha","year":"1998","journal-title":"BMJ"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1086\/605438","article-title":"Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment.","volume":"49","author":"S Sundar","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0035-9203(00)90131-7","article-title":"Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study.","volume":"94","author":"CP Thakur","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0035-9203(99)90037-8","article-title":"Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases.","volume":"93","author":"CP Thakur","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0924-8579(00)00312-5","article-title":"A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study.","volume":"17","author":"CP Thakur","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1179\/000349804225003154","article-title":"A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis.","volume":"98","author":"CP Thakur","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"key":"ref45","first-page":"582","article-title":"Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate.","volume":"127","author":"CP Thakur","year":"2008","journal-title":"Indian J Med Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/00034983.1998.11813313","article-title":"Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases.","volume":"92","author":"CP Thakur","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/516526","article-title":"Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis.","volume":"176","author":"S Sundar","year":"1997","journal-title":"J Infect Dis"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000818","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:48:04Z","timestamp":1588967284000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000818"}},"subtitle":[],"editor":[{"given":"Christine M.","family":"Budke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,9,7]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2010,9,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000818","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,7]]}}}